Review of QSAR Models and Software Tools for Predicting of Genotoxicity and Carcinogenicity

This review of QSARs for genotoxicity and carcinogenicity was performed in a broad sense, considering both models available in software tools and models that are published in the literature. The review considered the potential applicability of diverse models to pesticides as well as to other types of regulated chemicals and pharmaceuticals. The availability of models and information on their applicability is summarised in tables, and a range of illustrative or informative examples are described in more detail in the text. In many cases, promising models were identified but they are still at the research stage. For routine application in a regulatory setting, further efforts will be needed to explore the applicability of such models for specific purposes, and to implement them in a practically useful form (i.e. user-friendly software). It is also noted that a range of software tools are research tools suitable for model development, and these require more specialised expertise than other tools that are aimed primarily at end-users such as risk assessors. It is concluded that the most useful models are those which are implemented in software tools and associated with transparent documentation on the model development and validation process. However, it is emphasised that the assessment of model predictions requires a reasonable amount of QSAR knowledge, even if it is not necessary to be a QSAR practitioner.JRC.DG.I.6-Systems toxicolog

Investigation of in Silico Modelling to Predict the Human Health Effects of Cosmetics Ingredients

Animal experiments have been the standard method to assess the safety of chemicals used in cosmetic products for decades. However, public opinion has continued to demand that in vivo hazard identification methods conducted on animals are replaced with alternative methods. Research on alternative methods to replace in vivo toxicity testing continually increased over the past few decades with different alternatives developed, such as in vitro, in chemico and in silico approaches. Although different alternative techniques can be employed, no single technique can solely replace the complexity and an in vivo test, especially for chronic effects. Therefore, integrated testing strategies that can utilise the information from all available alternative testing approaches have been developed. Within the Adverse Outcome Pathway (AOP) paradigm, the molecular initiating event(s) MIE can be induced by several chemical key features which can be captured by structural alerts. When structural alerts for a MIE are compiled and supported by mechanistic and toxicity information confirming the induction of the same MIE, then they can be considered as an in silico profiler. The overall aim of the work presented in this thesis was to assess the current in silico profilers for carcinogenicity (both genotoxic and non-genotoxic), mutagenicity and skin sensitisation through assessment using multiple high-quality experimental databases. The research presented herein demonstrates the ability to assess the positive predictivity of two types of structural alert, mechanism- and chemistry-based that pertain to the endpoints and proposes ways to improve the overall accuracy of these profilers. In this context, this study has given an insight to those alerts that may be found equally in endpoint-positive or negative compounds, and those which may be more effectively utilised to form groups of analogues for read across predictions. A detailed analysis of positive predictivity of the available mutagenicity, carcinogenicity and skin sensitisation structural alerts and profilers Page 3 within the OECD QSAR Toolbox against experimental data is presented. This investigation showed the structural alerts that are accurate as such, and those that may need further refinement, or their use may need to be reconsidered. In addition, the relationship between scaffolds of a range of diverse compounds and carcinogenicity showed that a total of 17 carcinogenicity scaffolds could be identified from the available databases and could be used as a base for an in silico profiler. This work has also determined the need for further in-depth research in this area to study the suitability and merits of each of the alerts within the profilers currently included in the OECD QSAR Toolbox, and other in silico toxicity platforms, to identify the possibilities for improvement in their performance. This will, by implication, also improve the reliability of chemical read-across and grouping/categorisation for classification, labelling and risk assessment for regulatory use of the in silico methods

Developing genomic models for cancer prevention and treatment stratification

Malignant tumors remain one of the leading causes of mortality with over 8.2 million deaths worldwide in 2012. Over the last two decades, high-throughput profiling of the human transcriptome has become an essential tool to investigate molecular processes involved in carcinogenesis. In this thesis I explore how gene expression profiling (GEP) can be used in multiple aspects of cancer research, including prevention, patient stratification and subtype discovery. The first part details how GEP could be used to supplement or even replace the current gold standard assay for testing the carcinogenic potential of chemicals. This toxicogenomic approach coupled with a Random Forest algorithm allowed me to build models capable of predicting carcinogenicity with an area under the curve of up to 86.8% and provided valuable insights into the underlying mechanisms that may contribute to cancer development. The second part describes how GEP could be used to stratify heterogeneous populations of lymphoma patients into therapeutically relevant disease sub-classes, with a particular focus on diffuse large B-cell lymphoma (DLBCL). Here, I successfully translated established biomarkers from the Affymetrix platform to the clinically relevant Nanostring nCounter© assay. This translation allowed us to profile custom sets of transcripts from formalin-fixed samples, transforming these biomarkers into clinically relevant diagnostic tools. Finally, I describe my effort to discover tumor samples dependent on altered metabolism driven by oxidative phosphorylation (OxPhos) across multiple tissue types. This work was motivated by previous studies that identified a therapeutically relevant OxPhos sub-type in DLBCL, and by the hypothesis that this stratification might be applicable to other solid tumor types. To that end, I carried out a transcriptomics-based pan-cancer analysis, derived a generalized PanOxPhos gene signature, and identified mTOR as a potential regulator in primary tumor samples. High throughput GEP coupled with statistical machine learning methods represent an important toolbox in modern cancer research. It provides a cost effective and promising new approach for predicting cancer risk associated to chemical exposure, it can reduce the cost of the ever increasing drug development process by identifying therapeutically actionable disease subtypes, and it can increase patients’ survival by matching them with the most effective drugs.2016-12-01T00:00:00

Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach

Prostate cancer is a type of cancer that occurs in the male prostate, a gland in the male reproductive system. Because prostate cancer cells may spread to other parts of the body and can influence human reproduction, understanding the mechanisms underlying this disease is critical for designing effective treatments. The identification of as many genes and chemicals related to prostate cancer as possible will enhance our understanding of this disease. In this study, we proposed a computational method to identify new candidate genes and chemicals based on currently known genes and chemicals related to prostate cancer by applying a shortest path approach in a hybrid network. The hybrid network was constructed according to information concerning chemical-chemical interactions, chemical-protein interactions, and protein-protein interactions. Many of the obtained genes and chemicals are associated with prostate cancer

Antioxidant and DPPH-Scavenging Activities of Compounds and Ethanolic Extract of the Leaf and Twigs of Caesalpinia bonduc L. Roxb.

Antioxidant effects of ethanolic extract of Caesalpinia bonduc and its isolated bioactive compounds were evaluated in vitro. The compounds included two new cassanediterpenes, 1α,7α-diacetoxy-5α,6β-dihydroxyl-cass-14(15)-epoxy-16,12-olide (1)and 12α-ethoxyl-1α,14β-diacetoxy-2α,5α-dihydroxyl cass-13(15)-en-16,12-olide(2); and others, bonducellin (3), 7,4’-dihydroxy-3,11-dehydrohomoisoflavanone (4), daucosterol (5), luteolin (6), quercetin-3-methyl ether (7) and kaempferol-3-O-α-L-rhamnopyranosyl-(1Ç2)-β-D-xylopyranoside (8). The antioxidant properties of the extract and compounds were assessed by the measurement of the total phenolic content, ascorbic acid content, total antioxidant capacity and 1-1-diphenyl-2-picryl hydrazyl (DPPH) and hydrogen peroxide radicals scavenging activities.Compounds 3, 6, 7 and ethanolic extract had DPPH scavenging activities with IC50 values of 186, 75, 17 and 102 μg/ml respectively when compared to vitamin C with 15 μg/ml. On the other hand, no significant results were obtained for hydrogen peroxide radical. In addition, compound 7 has the highest phenolic content of 0.81±0.01 mg/ml of gallic acid equivalent while compound 8 showed the highest total antioxidant capacity with 254.31±3.54 and 199.82±2.78 μg/ml gallic and ascorbic acid equivalent respectively. Compound 4 and ethanolic extract showed a high ascorbic acid content of 2.26±0.01 and 6.78±0.03 mg/ml respectively.The results obtained showed the antioxidant activity of the ethanolic extract of C. bonduc and deduced that this activity was mediated by its isolated bioactive compounds